Asberry 22 Holdings Inc (ASHI)

[bernardsamuel]

Thanks, Knife, as ever. I think your point about the congruence of interests of the major stockholding group with that of the remaining shareholders can't be emphasized enough.

Meanwhile, one overlooked aspect at this time of our all concentrating on the upcoming transaction is how deeply the stock appears to be undervalued currently without consideration of an upcoming transaction, based particularly on sales growth and the first quarter bottom line, even before one might consider how much more a transaction would bring to the share price. it would appear to me, the way things seem to be going, that the company would actually be likely to be able to pay for a large measure of the costs of FDA compliance, even if assuming no pullback on the regulations, through earnings-generated funds.

Best wishes!